Sigma Planning Corp lessened its holdings in Anthem Inc (NYSE:ANTM) by 29.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,819 shares of the company’s stock after selling 744 shares during the period. Sigma Planning Corp’s holdings in Anthem were worth $437,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in ANTM. Cox Capital Mgt LLC increased its position in Anthem by 3.1% during the second quarter. Cox Capital Mgt LLC now owns 2,424 shares of the company’s stock worth $684,000 after purchasing an additional 74 shares during the last quarter. Pensionfund DSM Netherlands boosted its stake in Anthem by 14.3% during the 2nd quarter. Pensionfund DSM Netherlands now owns 11,425 shares of the company’s stock valued at $3,224,000 after acquiring an additional 1,425 shares during the last quarter. Pensionfund Sabic boosted its stake in Anthem by 9.3% during the 2nd quarter. Pensionfund Sabic now owns 7,650 shares of the company’s stock valued at $2,159,000 after acquiring an additional 650 shares during the last quarter. Fulton Bank N.A. boosted its stake in Anthem by 9.3% during the 2nd quarter. Fulton Bank N.A. now owns 8,337 shares of the company’s stock valued at $2,353,000 after acquiring an additional 710 shares during the last quarter. Finally, Silverleafe Capital Partners LLC bought a new position in Anthem during the 2nd quarter valued at $2,509,000. Institutional investors and hedge funds own 89.09% of the company’s stock.
Shares of NYSE:ANTM traded up $2.32 on Friday, reaching $282.09. 1,213,272 shares of the company’s stock were exchanged, compared to its average volume of 1,697,421. The firm has a market capitalization of $69.22 billion, a price-to-earnings ratio of 17.75, a PEG ratio of 1.01 and a beta of 0.74. Anthem Inc has a fifty-two week low of $227.16 and a fifty-two week high of $317.99. The business’s 50-day moving average is $252.84 and its two-hundred day moving average is $270.42. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.60.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Thursday, December 5th will be issued a dividend of $0.80 per share. The ex-dividend date is Wednesday, December 4th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 1.13%. Anthem’s dividend payout ratio (DPR) is 20.14%.
In related news, EVP Peter D. Haytaian sold 9,586 shares of the stock in a transaction dated Monday, October 28th. The shares were sold at an average price of $269.57, for a total value of $2,584,098.02. Following the sale, the executive vice president now owns 42,488 shares of the company’s stock, valued at approximately $11,453,490.16. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.17% of the stock is owned by company insiders.
A number of research analysts have commented on ANTM shares. Deutsche Bank started coverage on shares of Anthem in a research note on Thursday, September 12th. They set a “buy” rating on the stock. Credit Suisse Group reduced their price objective on shares of Anthem from $345.00 to $340.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. ValuEngine downgraded shares of Anthem from a “hold” rating to a “sell” rating in a research note on Friday, November 1st. Morgan Stanley increased their target price on shares of Anthem from $356.00 to $360.00 and gave the stock an “overweight” rating in a report on Thursday, October 24th. Finally, Zacks Investment Research cut shares of Anthem from a “buy” rating to a “hold” rating and set a $289.00 target price on the stock. in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and thirteen have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $319.72.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.